These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10240261)

  • 41. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The costs of compliance.
    Leeman E
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):179-87. PubMed ID: 17650971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 44. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Off-label" psychotropic medication use in children.
    Regan J; Alderson A
    Tenn Med; 2003 Sep; 96(9):429-31. PubMed ID: 14513532
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of recent black box warnings in the allergy world.
    Oppenheimer J; Aaronson D
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):364-6. PubMed ID: 17941285
    [No Abstract]   [Full Text] [Related]  

  • 47. How to help your low-income patients get prescription drugs.
    Montemayor K
    Fam Pract Manag; 2002; 9(10):51-6. PubMed ID: 12469677
    [No Abstract]   [Full Text] [Related]  

  • 48. [Patient compliance--possibilities for improvement].
    Steiner A; Vetter W
    Praxis (Bern 1994); 1995 Jan; 84(3):58-62. PubMed ID: 7846429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving adherence to drug-treatment regimens for glaucoma.
    Mansukani SS
    Manag Care; 2002 Nov; 11(11 Suppl):49-53. PubMed ID: 15357540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of drugs for unapproved indications: your legal responsibility.
    Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969
    [No Abstract]   [Full Text] [Related]  

  • 53. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 54. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 55. Help your patients become aware of the new medicare prescription drug plans.
    McClellan M
    Oncologist; 2005 Sep; 10(8):563-4. PubMed ID: 16177280
    [No Abstract]   [Full Text] [Related]  

  • 56. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 57. Off-label drugs: question your doctor.
    Consum Rep; 2007 Jun; 72(6):47. PubMed ID: 17632948
    [No Abstract]   [Full Text] [Related]  

  • 58. PPIs: community pharmacists' perceptions.
    Kaczmarek ER; Stewart JE; Hutchinson RA
    Contemp Pharm Pract; 1982; 5(3):143-9. PubMed ID: 10256917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FDA chief says demand by patients for more drug information is genuine.
    Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug labeling for laymen?
    Regier H
    J Leg Med (N Y); 1976 Jan; 4(1):15-6. PubMed ID: 1082471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.